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Abstract
Background: Trimethoprim is a widely prescribed antibiotic for a variety of bacterial infections. It belongs to a
class of anti-metabolites - antifolates - which includes drugs used against malarial parasites and in cancer therapy.
However, spread of bacterial resistance to the drug has severely hampered its clinical use and has necessitated
further investigations into its mechanism of action and treatment regimen. Trimethoprim selectively starves
bacterial cells for tetrahydrofolate, a vital cofactor necessary for the synthesis of several metabolites. The outcome
(bacteriostatic or bactericidal) of such starvation, however, depends on the availability of folate-dependent
metabolites in the growth medium. To characterize this dependency, we investigated in detail the regulatory and
structural components of Escherichia coli cellular response to trimethoprim in controlled growth and
supplementation conditions.
Results: We surveyed transcriptional responses to trimethoprim treatment during bacteriostatic and bactericidal
conditions and analyzed associated gene sets/pathways. Concurrent starvation of all folate dependent metabolites
caused growth arrest, and this was accompanied by induction of general stress and stringent responses. Three
gene sets were significantly associated with the bactericidal effect of TMP in different media including LB: genes of
the SOS regulon, genes of the pyrimidine nucleotide biosynthetic pathway and members of the multiple antibiotic
resistance (mar) regulon controlled by the MarR repressor. However, the SOS response was identified as the only
universal transcriptional signature associated with the loss of viability by direct thymine starvation or by folate
stress. We also used genome-wide gene knock-out screen to uncover means of sensitization of bacteria to the
drug. We observed that among a number of candidate genes and pathways, the effect of knock-outs in the
deoxyribose nucleotide salvage pathway, encoded by the deoCABD operon and under the control of the DeoR
repressor, was most informative.
Conclusion: Transcriptional induction of DNA damage response is an essential feature of the bactericidal effect of
trimethoprim. Either the observation of the transcriptional response or DNA damage itself, or both, is made
possible by thymine starvation when other folate-dependent metabolites are not limited. The effect of DNA
damage by the drug takes place prior to its bactericidal effect, at the beginning of the lag stage of the treatment.
Mutations in the deoxyribose nucleotide salvage pathway can affect duration of the lag as well as the rate of
killing. This information can be used to postulate certain mechanistic differences between direct thymine starvation
in thymidylate synthase deficient mutants and thymine starvation by anti-folate inhibitors.
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2,4,-diamino-5-(3’,4 ’,5 ’-trimethoxybenzyl)-pyrimidine
(Trimethoprim, TMP) is a folate analog that inhibits the
reduction of dihydrofolate to tetrahydrofolate (THF) by
competitively binding the active site of the enzyme dihy-
drofolate reductase (DHFR) [1,2]. The drug is highly
specific against bacterial and malarial enzymes [3], has a
wide antibacterial spectrum and, despite emerging resis-
tance [4-7], has been extensively used against urinary
and respiratory tracts infections and against enteric
pathogens and methicillin resistant S. aureus [8].
Trimethoprim treatment reduces the pool of 5,6,7,8-
tetrahydrofolate (THF) by inhibiting DHFR, encoded by
the folA and folM genes in E. coli (Figure 1). THF is
methylated during the synthesis of glycine from serine
and gets converted to 5,10-methylenetetrahydrofolate
(CH2-THF), which is a major one-carbon donor in the
cell for the synthesis of methionine and S-adenosyl-
methionine (SAM), purines, N-formylmethionine-tRNA
(fMet-tRNA) and thymidylate (dTTP) [9,10]. Thus TMP
treatment leads to the loss of THF pools to dihydrofo-
late because of thymidylate synthesis. This causes con-
comitant starvation of glycine, methionine, purines,
dTTP (folate dependent metabolites) and fMet-tRNA,
with some metabolites being depleted faster than others
[11,12], and results in nearly complete cessation of
DNA, RNA and protein synthesis [11,13,14]. Other
pathways affected due to depletion of SAM, a major
methyl group donor, include synthesis of cofactors, fatty
acids and polyamines. Starvation of cells for purines and
amino acids is usually bacteriostatic; starvation of dTTP
alone leads to loss of viability and is known as “thymine-
less death” [15-17]. Therefore, cellular outcome of TMP
treatment depends on the balance of folate dependent
metabolites in the cell and on the media supplementa-
tion conditions; cell death depends upon the right com-
bination of supplementation regimes resulting, in part,
in thymine starvation [15,16]. Thus in controlled envir-
onment in the laboratory, the outcome of TMP treat-
ment can in principle be correlated with the
composition of the growth medium. However, despite a
general understanding of the drug mechanism, the fol-
lowing key aspects of the antibacterial activity of TMP
remains unknown: i) what is the molecular nature of
folate stress induced by the drug?; ii) what is the rela-
tionship between the folate stress and media composi-
tion?; iii) what are the similarities and differences
between bacateriostatic and bactericidal signatures of
the TMP effects.
To answer these and related questions, we treated
Escherichia coli with TMP in a variety of media and
supplementation conditions and tracked global tran-
scriptional responses using microarrays. We also applied
a genome-wide genetic screen to identify gene knock-
out mutants with decreased or increased susceptibility
to TMP in rich media. We observed that the drug treat-
ment, either in minimal medium supplemented with
requisite amino acids and adenine or in complex med-
ium (LB), resulted in the loss of viability and this loss
was correlated with the induction of DNA damage
repair genes. Under limited supplementation conditions
(only amino acids or purines) in minimal media, the pri-
mary signature was that of stress response, but when
both were added in absence of thymine, the stress
response signature was not observed. Addition of indivi-
dual supplements (amino acids or purine) also led to
the repression of the respective biosynthetic genes, even
in the presence of TMP. We also identified a signature
of gene set activity, including induction of DNA damage
response, pyrimidine nucleotide biosynthesis and anti-
biotic stress responsive MarR targets to be most asso-
ciated with cell lethality in minimal media. However,
only the SOS response was associated with the bacterici-
dal outcome across all tested nutrient conditions,
including thymine starvation in a thymine auxotroph.
Using a genome-wide collection of knock-out mutants
to screen for genetic, rather than environmental, factors
that can affect TMP susceptibility, we found that the
deoxyribose nucleotide salvage pathway has the capacity
to modulate and mediate the effect of the drug. The
deoA and deoC gene knock-out mutants were found to
be resistant to TMP in complex medium, whereas the
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Page 2 of 14loss of their transcriptional repressor deoR rendered
bacteria more sensitive to the drug. However, this rela-
tionship was reversed in minimal medium with supple-
ments. This reversal was also observed at the
transcriptional level wherein the deoCA genes were
down-regulated during TMP treatment in LB medium
and up-regulated in M9 minimal medium. Using this
data and other available information we propose that
t h en u c l e o t i d es a l v a g ep a t h w a ye n c o d e db ydeoCABD
genes is a critical modulator of physiological outcomes
of the TMP treatment in E. coli.
Methods
Growth conditions
Escherichia coli MG1655 F
- lambda
- ilvG
- rfb-50 rph
-
was used as a wild-type strain in all experiments. Tri-
methoprim (Fluka (Sigma-Aldrich), St. Louis, MO) stock
solution was prepared by dissolving the drug in distilled
water with 1% v/v glacial acetic acid (for Keio screen) or
by dissolving in 50% v/v ethanol-chloroform mixture
(for transcriptional profiling) and stored in small ali-
quotes at -20°C. Complex medium for cell growth was
LB (Luria Bertani broth) and minimal medium was M9
minimal medium with 0.4% glucose [18]. In LBTMP
experiments, cells were treated with 50 μg/ml of TMP,
while for M9 experiments the concentration used was
25 μg/ml, corresponding to the MIC50 determined in
the respective media after 18 hrs of treatment. Amino
acids for supplementation (methionine and glycine)
were purchased from Fluka (Sigma-Aldrich, St. Louis,
MO) and stock solutions were prepared in water. Stan-
dard cultures were grown in flasks at 37°C under aera-
tion in a rotary shaker either in M9 minimal medium
containing 0.4% glucose or in LB liquid medium. For
M9 with folate dependent supplementation experiments,
the following chemicals were added with a final concen-
tration of 50 μg/ml: adenine, amino acid (methionine
and glycine) mixture, and thymine.
Microarray experiments
Overnight cultures were resuspended in fresh medium and
TMP was added when the optical density (O.D. 600 nm)
of the culture reached 0.3-0.4. Time-point samples were
taken every 15-30 minutes from 15 minutes to 2 hours
post treatment. The samples were spun down and snap-
frozen in liquid nitrogen before storing at -80°C until
required. Total RNA samples were purified using the Qia-
gen RNeasy kit (Chatsworth, CA) according to the manu-
facturer’s protocol. To identify genome-wide gene
expression profiles, relative mRNA levels were determined
by parallel two color hybridization at single-gene resolu-
tion to whole-genome E. coli K-12 MG1655 spotted DNA
microarrays, designed, printed and probed as described
[19], and containing discrete sequence elements
corresponding to 98 and 3/4% of all annotated open read-
ing frames (ORFs). Fluorescence DNA probes were
synthesized from 10~15 μg of total RNA with random
hexamers and Cy-5 dUTP or Cy-3 dUTP dyes (Amer-
sham) and hybridized to microarrays for 6 hours at 65°C
followed by a washing step as described previously [19].
All microarray experiments were designed as time courses,
using the 0 min time point sample as a common reference.
The hybridized arrays were then scanned and the raw
fluorescence intensity data were normalized in R (http://
cran.r-project.org/) using the Limma (Bioconductor) pack-
age [20] to remove spatial and array based biases. The
data was converted to log-ratios of normalized intensity at
each time point to time point 0. The microarray data was
uploaded to NCBI GEO database and is available for
download through accession number GSE32562.
Gene Set Analysis
To analyze gene expression data in the context of known
gene sets and pathways, we obtained gene functional
classification information from databases (GenProtEC
[21], RegulonDB [22], EcoCyc [23]) to assemble a total of
480 gene sets (Additional File 1). These comprise of sets
of genes whose products are involved in the same path-
way and sets of genes that share common regulators or
other properties. Normalized gene expression data was
analyzed for gene set activity using a method modified
from Tian et al [24]. We then modeled the normalized
set scores across the entire time series to analyze the
effect of individual supplements on gene set activity and
to infer set activity associated with the lethal phenotype.
The raw gene set score for k
th gene set was calculated as:
Sk =
Nk 
i=1
wiTi
where wi corresponds to the contribution of gene i
within a set to the principal eigenvector of the set across
a compendium of experimental conditions [25] and Nk
is the number of genes in gene set k.T h ew e i g h t sa l l o w
us to consider sets that only have a subset of actively
transcribed genes or sets with genes showing opposite
but coordinated trends [26,27]. The score S was normal-
ized under two sets of hypothesis Q1 and Q2 [24], corre-
sponding to testing against random genes and random
phenotypes, to yield two normalized gene set scores for
each gene set. This was done by randomly sampling
genes (in Q1) or conditions (in Q2) and then calculating
the bootstrapped scores under these permutations.
These null scores are normalized to mean 0 and stan-
dard deviation 1 to account for gene set size depen-
dence of the distributions. The observed gene set scores
Sk were also normalized using the parameters of the
null distributions. P-values calculated for both Q1 and
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significance, which is mathematically equivalent to the
local False Discovery Rate (FDR) value of the score [28],
and PP values from both hypotheses were multiplied,
under assumption of independence, to yield the final PP
for the gene set. PP values of greater than 0.90 (estimated
FDR ~ 5%) were considered to be highly significant. The
normalized scores in the two hypotheses for gene set were
averaged to yield a enrichment score (ES), which allows us
to quantitatively compare two or more gene sets within a
condition or a gene set across conditions, and its sign indi-
cates the direction of change (up- or down-regulation)
within the set. To infer effects of individual supplementa-
t i o n ,t h es e ts c o r e s( E S )f o rt h ee n t i r et i m es e r i e so fM 9
treatments were modeled as:
ESi = βAA
i AAi + βAd
i Adi + β
Thy
i Thyi + εi
where ESi is the vector of set scores of set i;A A i,A d i
and Thyi are factors with level 1 (if the respective sup-
plements are added) or 0. M9TMP condition has all
three factors at level 0 since none of the supplements
were added. A positive coefficient for any factor indi-
cates that the addition of the supplement is associated
with increase in set score relative to its baseline level.
For inferring associations with cell lethality, set scores
from both LB and M9 experiments were considered. To
account for the influence of latent variables affecting the
set scores, surrogate variable analysis (SVA, [29]) was
used to model the hidden variables as a covariate:
ESi = βSV
i SVi + βPhe
i Phei + εi
where ESi is the vector of set scores for set i,S V i are sur-
rogate variables and Phei represents a vector of pheno-
types associated with the set (factor with two levels: “cidal”
or “static”). Parametric p-values associated with the esti-
mated coefficients βPhe
i were obtained by ANOVA, and
False Discovery Rates (q-value [30]) was calculated to infer
significant gene sets. A q-value of 5% indicates all sets
with the same or lower q-value are called significant at 5%
False Discovery Rate. All calculations were done in R.
Non-parametric classification based on Receiver-Operator
Characteristics (ROC) curves were done by using the R
package “caTools”[31]. AUC values of 0.85 and higher
were considered significant, and it was used as the second
threshold to filter significant gene sets. The entire data
and the R code to reproduce the analysis can be found in
Additional File 2.
Genome-wide genetic screen
The Keio collection was a kind gift of Prof. Hirotada
M o r ia n dc o n s i s t so fk n o c k - o u tm u t a n t so f3 9 8 5g e n e s
of E. coli strain BW25113 [32]. The knock-out mutants
contain Kan
R cassettes inserted in genes using the
method of Datsenko and Wanner [33]. For mutant
screening, a copy of the mutant plates was made by
replica inoculating the frozen stocks into 96-well plates
containing 150 μl of LB medium and incubating them at
30°C for 12-18 hours with intermittent shaking. For
growth and inhibition experiments, the optical density
in the wells of the 96-well plate was measured using
Victor3 plate reader (Perkin-Elmer). The actual O.D.
reading in the plate reader depends on the medium and
the volume of liquid in the wells and is correlated with
actual culture density measured by conventional light
scattering techniques (r
2 > 0.99) for O.D. 0.1-1.0. Since
each plate was inoculated as a set, there was plate-to-
plate variation in O.D. that was accounted for by nor-
malizing across plates. Resistant and sensitive mutants
were identified by normalized O.D. readings. Mutants in
Keio collection are in BW25113 background. For indivi-
dual mutant analysis, the Kan
R insertion alleles were
transferred into wild-type MG1655 background using
P1-transduction [34]. An E. coli thyA715 mutant
MG1655 was obtained from CGSC. Different deo muta-
tions were similarly introduced into the thyA
- parental
strain. thyA
-deo
- double mutants had different thymine/
thymidine growth requirements; thyA
- 20 μg/ml thy-
mine, thyA
-deoA
- 20 μg/ml thymidine, thyA
-deoC
- 2 μg/
ml thymine, thyA
-deoR
- 50 μg/ml thymine [35,36] For
viability experiments and RNA sampling, the cultures
were handled as follows. Cells were grown to stationary
phase in LB or M9 minimal media (with glucose). They
were then inoculated in fresh medium and grown till O.
D. 0.4-0.6 before treatment. For TMP treatment in LB,
TMP was added to appropriate final concentrations. For
TMP treatment in minimal medium, growing cultures
were diluted in pre-warmed fresh minimal medium con-
taining TMP and methionine, glycine, adenine supple-
ments. For viability counts, samples were diluted in
0.9% NaCl, spread or spotted on LB plates and incu-
bated 12-16 hours before colony counts were taken.
Results and Discussion
Folate supplementation regimes determine bacterial
viability phenotypes
The effect of antibiotic trimethoprim (TMP) on bacteria
depends on the treatment conditions. To characterize
the cellular responses associated with these effects, we
treated E. coli with the antibiotic in different growth
and supplementation conditions: complex medium
(LBTMP), minimal medium M9 (M9TMP), and minimal
medium supplemented with folate dependent metabo-
lites, amino acids methionine and glycine (M9TMPAA),
adenine (M9TMPAd), amino acids and adenine
(M9TMPAdAA), and M9 supplemented with the amino
acids, adenine and thymine (M9TMPThyAdAA) (Table
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different outcomes in TMP treatment: only in minimal
medium the treatment results in growth arrest, supple-
mentation with both AA and Ad leads to cell killing,
and addition of thymine rescues cells from the effects of
the drug [15]. We followed the effects of the drug treat-
ment by monitoring colony formation, as a proxy to cell
viability, and genome-wide transcriptional responses, as
a proxy to physiological changes elicited by the drug. As
expected, cell viability in minimal medium depended on
supplementation of the folate-derived metabolites. TMP
treatment in M9 resulted in cessation of growth without
a loss of viability, whereas M9TMPAdAA condition
resulted in killing (Table 1) after a lag period, along
with increase in cell mass due to filamentation (data not
shown). Thymine supplementation prevented viability
loss in the bacterial culture, confirming that the primary
mechanism of TMP induced cell death is due to thy-
mine starvation [15]. Incomplete supplementation either
by the amino acids or by the purine resulted in bacter-
iostasis. LBTMP condition resulted in loss of viability
after a lag period of approximately 120 min, as well as
in filamentation.
Effects of individual supplementation regimes
Given the diverse nature of phenotypes generated by the
combination of TMP and media conditions, and the
complex nature of folate metabolism being perturbed, it
is essential to identify key molecular events during each
treatment that are associated with the observed pheno-
type. We first followed transcriptional responses to TMP
treatment in these conditions as a time series using
cDNA microarrays and obtained gene expression profiles
as ratios of transcript abundances after the treatment (10
- 120 minutes) normalized to the before-treatment levels
(0 minutes). To develop a biological interpretation of
these responses, we examined transcriptional activity of
sets of genes [24]. Briefly, for each time point in each
condition, the activity score (Sk) for each gene set was
calculated as the weighted average of all the genes within
the gene set (Methods). The score was then normalized
using background null distributions [24] to get the
enrichment scores (ES) and the p-values for these scores
were then converted to a posterior probability (PP, [28])
to adjust for multiple testing. The PP value (1 for strong
enrichment, 0 for no enrichment), along with the enrich-
ment score ES, allowed for quantitative comparison of
different gene sets in different conditions. PP values of
greater than 0.90 were considered to be highly significant
for gene set activity, corresponding to false discovery
rates of less than 5% for the conditions.
The effect of TMP in different supplementation condi-
tions can be viewed and analyzed as an interaction
between the effects of the drug effect and the condition.
Traditionally, the effect of a drug would be ascertained
in cultures adapted over multiple generations to their
growth environments. While such approach may seem
physiologically most sound, it does not allow determin-
ing the media specific effects in any straightforward way,
in part because of a prolonged adaptation and resulting
steady state are accompanied by macroscopic growth
and metabolic differences which can mask nutrient-spe-
cific regulation. This has not been seen as a serious pro-
blem since for most actively studied antibacterials, the
media composition either does not have an effect on the
outcome of the treatment or its effects are not known.
This however would be a serious problem for TMP
treatments where media composition effects have been
well documented. Therefore we designed our experi-
ment in a way that yielded physiologically meaningful,
and consistent with historical data, media-dependent
outcomes of the treatments and also allowed detecting
direct regulatory effects of the supplementations.
According to such design, the drug was added to the
cell cultures along with the supplements and transcrip-
tional responses were recorded immediately afterwards.
Thus the ensuing regulatory and physiological changes
in the cells will be, by definition, a result of the combi-
nations, or interactions, of the effects of the drug and
supplements. Modeling these transcriptional responses
as estimated additive effects of each supplement could
help us explain these interactions as simple cause and
effect representation for each individual factor-gene set
pair.
Table 1 Treatment regimens used for gene expression analysis
Condition Base medium Supplementation Viability loss
LBTMP Luria-Bertani broth - + (90% loss in 3 hours)
M9TMP Minimal M9 None -
M9TMPAdAA Minimal M9 Met, Gly, Ad + (>70% loss in 6 hours)
M9TMPAA Minimal M9 Met, Gly -
M9TMPAd Minimal M9 Ad -
M9TMPThyAdAA Minimal M9 Met, Gly, Ad, Thy -
A list of treatment regimens used. Viability loss indicates the relative magnitude of cell lethality (+: maximum, -: no loss). TMP: Trimethoprim (50 or2 5μg/ml),
Met: methionine, Gly: glycine, Ad: adenine (each at 50 μg/ml final concentration)
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met, gly, Ad: adenine and Thy: thymine) on the TMP-
induced folate stress, we employed a linear model using
set scores across all time points for each condition and
with individual supplements as factors, to identify the
gene sets with the highest absolute coefficients asso-
ciated with each factor. In total, 16 overlapping gene
sets have been identified with a significant coefficient in
at least one condition (Additional File 3). The sets have
been grouped based on the similarity of associated coef-
ficients across all conditions into eight clusters (Figure
2): 1-histidine and glycine metabolism; 2 - sulfate assim-
ilation; 3 - general stress response; 4 - methionine trans-
port and metabolism; 5 - DNA damage response and
repair; 6 - purine biosynthesis; 7 - protein synthesis
machinery; 8 - enterochelin biosynthesis. TMP, by virtue
of its anti-DHFR mechanism, triggers different starva-
tion responses depending on the exogenous supply of
respective metabolites, as evidenced from the variations
in the activity of the most responsive gene sets (Figure
2A-E). Without any supplementation, the drug induced
amino acid and nucleotide starvation which could be
characterized by severe down-regulation of ribosomal
and purine biosynthetic genes, transient up-regulation of
the methionine cluster of genes, and by late and mini-
mal up-regulation of the damage response cluster (Fig-
ure 2A). Targets of RpoS, a stress signal responsive
regulator, were also significantly up-regulated in this
condition (PP > 0.998), indicating that starvation for
amino acids and nucleotides was followed by a general
stress response in the cells. Starvation for amino acids
and thymine (Figure 2B) was characterized by the
down-regulation of the purine cluster and up-regulation
of the methionine cluster. Addition of adenine also low-
ered the extent of repression of genes encoding transla-
tion proteins as compared to TMP alone. Starvation for
thymine and purines (Figure 2C), on the other hand,
resulted in relative down-regulation of the methionine
and sulfate assimilation clusters and in an up-regulation
of glycine cleavage pathway as a response to added gly-
cine, and in a moderate, more pronounced than in the
TMP alone condition, but late up-regulation of the
DNA damage genes. Histidine biosynthesis was also up-
regulated relative to the conditions without AA, which
is an expected response to external methionine [25].
When cells were starved only for thymine (Figure 2D),
 Histidine synthesis
 Glycine cleavage  
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 S-adenosyl methionine biosynthesis 
 Methionine transport 
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 Purine biosynthesis  
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Figure 2 Expression profiles of top gene sets associated with individual supplementation of folate-dependent metabolites. Heatmap of
gene set scores for top gene sets associated with individual factors. Blue and yellow color refers to down-regulation and up-regulation of gene
sets respectively. Colored triangles above the heatmap indicate time progression from 10 min to 120 min after the beginning of drug treatment.
The figure is split into vertical panels A-E according to the condition and into horizontal strips according to the gene set.
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damage, protein and enterochelin synthesis. Other gene
clusters in this condition were either unaffected or
down-regulated. Addition of thymine along with other
supplements (Figure 2E) prevented the inductions
observed in the thymine starvation. However, thymine
supplementation had no effect on the activity of genes
controlling purine biosynthesis, sulfate assimilation, as
well as amino acid transport and metabolism. Thus thy-
mine counteracted the antibacterial effect of TMP and
suppressed DNA damage response and transcriptional
over-drive of genes involved in protein synthesis. At the
same time, specific regulatory responses associated with
the addition of adenine or amino acids were not com-
plemented by the nitrogen base.
Identification of a transcriptional signature associated
with lethality
The analysis presented in the above section supports the
notion that TMP regulatory effects can be complemen-
ted by different metabolic supplements. Since, on the
other hand, supplementation regimes are known to elicit
different phenotypic outcomes of the drug treatment, it
follows, from the transitivity principle, that the regula-
tory effects should be associated with the outcomes.
However, since the above analysis included only one
bactericidal condition (M9TMPAdAA), we chose to
boost the power of our association analysis by adding
another bactericidal condition: TMP treatment in LB.
To determine which pathway responses were most asso-
ciated with the phenotype of rapid loss of viability, we
classified the gene set scores according to the lethality
phenotypes, i.e. large (>50% of the treated population)
loss of viability in M9TMPAdAA and LBTMP vs. no or
minimal loss (< 10%) in M9TMPThyAdAA, M9TMP,
M9TMPAd and M9TMPAA (Figure 3). The top gene
sets associated with the phenotype were related to DNA
damage response (partially overlapping Multifun cate-
gories: DNA repair and SOS response and targets of
LexA; FDR < 0.01%; Additional Files 4, 5) and DNA
recombination, which were up-regulated in the bacteri-
cidal conditions as compared to no change in the static
conditions. Other gene sets in the top category com-
prised of ribosomal proteins, targets of MarR (multiple
antibiotic resistance response), enterochelin biosynthesis,
OxyR targets and pyrimidine biosynthesis (up in cidal,
Media/Treatment dependent response
Media independent/Treatment dependent response
Media and Treatment independent response
 DNA repair 
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Figure 3 SOS response is uniquely associated with thymineless induced lethality across treatment regimens and growth conditions.
Heatmap of gene set scores associated with TMP treatment and thymineless death (TLD)[37]. Blue and yellow color refers to down-regulation
and up-regulation of gene sets respectively. Condition labels are as described in Table 1. dRP: deoxyribosephosphate; SS: supercoiling; PBP:
periplasmic binding proteins.
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Page 7 of 14down or no change in static; “TMP treatment” in Figure
3, Additional Files 4, 5). This was in contrast with genes
in deoxyribose nucleotide salvage pathways (including
targets of CytR and DeoR) which were down-regulated
in cidal conditions compared to the static. In particular,
the salvage pathways were strongly down-regulated in
complex LB medium. Iron uptake associated enteroche-
lin biosynthesis, periplasmic binding proteins and targets
of nitrogen assimilation regulator Nac were relatively
down-regulated in the static conditions compared to
cidal. Since the significance of the association depends
on the scale of the calculated set scores, we also imple-
mented a non-parametric classification method based
on receiver-operator characteristics (ROC) to identify
the specificity and sensitivity of phenotype prediction
(AUC score) based on individual set scores. When top
ranked gene sets from both methods, based on FDR for
association and the AUC value for ROC-based classifica-
tion, were combined by averaging the top gene set
ranks, there was a significant overlap between the gene
sets ranked by both methods (Spearman rank correla-
tion over all gene sets = 0.96, p-value < 10
-16 ;A d d i -
tional File 6). When the responses of these top pathways
were compared across all examined conditions (cidal
and static conditions and complex and minimal media),
transcription of only three non-redundant sets - SOS
and related DNA damage gene classes, pyrimidine bio-
synthesis and MarR targets - was affected by the drug in
t h es a m ed i r e c t i o n ,i . e . ,t h ese pathways were up-regu-
lated in each TMP-induced bactericidal condition
("TMP Treatment” in Figure 3). Directionality of tran-
scriptional responses of the rest of the pathways
depended on the media. For example, salvage pathways
of deoxyribonucleotides, which were significantly asso-
ciated with lethality, were down-regulated in LBTMP,
but were not affected in M9TMPAdAA and were only
moderately up-regulated in the static conditions. Simi-
larly, ribosomal proteins were moderately down-regu-
lated in LBTMP but strongly up-regulated in
M9TMPAdAA. Thus, SOS response, pyrimidine bio-
synthesis and MarR targets, which controls transcription
of genes involved in multidrug efflux, form the media
independent signature responses associated with the
bactericidal effect of the antibiotic.
To further compare transcriptional sensitivities of
these gene sets, we scored their responses in another
thymine starvation condition, triggered by thymine with-
drawal from a thyA strain ("Thymine starvation” in Fig-
ure 3). We observed that the SOS response followed the
up-regulation trend following the treatment, while pyri-
midine biosynthesis was down-regulated and MarR tar-
gets were not affected. Thus, we propose that the
induction of the DNA damage response is the only tran-
scriptional effect associated with thymineless death
phenomenon observed across a variety of experimental
conditions including thymine starvation of auxotrophic
mutants, starvation of dTMP using TMP in the presence
of supplements or using TMP in complex growth media;
whereas up-regulation of pyrimidine synthetic genes and
MarR targets is associated with lethality only in TMP
treatments. Of note, when we examined a compendium
of expression profiles for activity of the MarR regulon,
we observed that other top conditions in which MarR
targets were up-regulated were treatments with antibac-
terials and antibiotics including Norfloxacin, Streptomy-
cin, Kanamycin, Indole-acrylate and Chloramphenicol
(data not shown). Since all of these treatments were car-
ried out in LB, and the current identification of the
MarR signature was driven by the LBTMP condition, it
is possible that de-repression of MarR targets is a result
of interaction(s) between yet unidentified factors asso-
ciated with growth in a rich medium and the generic
antibiotic induced stress.
We previously reported that the DNA damage
response was the primary transcriptional response that
separated thymine starvation leading to thymineless
death (TLD) in thyA auxotrophs from the thymine lim-
itation (TLM) wherein cells were supplied with subopti-
mal amounts of thymine [37]. Here, we showed that the
SOS response was also significantly associated with cell
death by TMP in minimal medium supplemented with
folate metabolites or in complex medium. The genes
involved in SOS response were observed to be signifi-
cantly induced in bactericidal conditions as compared to
static conditions after 30 minutes of treatment (One-
sided t-test p-value = 0.004) and at later time points. No
loss of viability was observed in cidal conditions in
either media at this time point, indicating that DNA
damage precedes viability loss and thus may be causa-
tive to cell lethality.
Genome-wide genetic screen for TMP susceptibility
To complement a genome-wide transcriptional survey,
we assessed the relative fitness contribution of individual
gene products under TMP stress by using a forward
genetic screen. To do so, we used the Keio collection of
Escherichia coli BW25113 knock-out strains affecting
3985 individual genes [32] to screen for mutants whose
growth was resistant or sensitive, as compared to wild-
type, to sub-lethal concentration of TMP in LB complex
medium. After 24 hours of incubation, the final yield of
biomass of the mutants was measured as optical density
(O.D.) using a plate reader. Since the mutants were
arranged in 96-well plates randomly, outliers on each
p l a t ew e r ei d e n t i f i e da sn o r malized O.D. readings that
deviated significantly from the average on each plate. A
list of top 100 resistant and sensitive candidates was
assembled from all plates and was compared to a
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Page 8 of 14replicate assay. The O.D. of the highest yielding mutants
was on average 6-fold higher than that of the lowest
mutants in this sub-lethal concentration, and were about
70% higher than the average mutant. A total of 18 and 13
gene knock-outs had reproducible high-yield (enrichment
p-value < 10
-16)a n dl o w - y i e l d( p<1 0
-6)p h e n o t y p e s ,
respectively, and are listed in Tables 2 and 3.
The gene tdk encodes thymidine kinase, which con-
verts thymidine to thymidine monophosphate dTMP
(Figure 1). In the absence of tdk, cells exclusively rely
on tetrahydrofolate dependent conversion of dUMP to
dTMP, which is inhibited during TMP treatment. Cells
without tdk should be therefore unable to grow, and
indeed a tdk knock-out was identified as a sensitive
mutant in the assay. This was verified by the observation
of rapid loss of viability of tdk mutant after 50 μg/ml
TMP addition in liquid culture (data not shown). Other
mutants imparting sensitivity to TMP included several
knock-outs of the genes of chemotaxis pathway (fliD,
fliL, fliN, flgH)a n do fhda, a regulatory inhibitor of the
replication initiator protein DnaA. Inactivation of Hda is
a major cause of DnaA-dependent over-initiation of the
chromosomal replication [38], and recent studies have
proposed a link between aberrant DNA replication
initiation and TLD [37,39,40]. High-yielding mutants
could in principle be genuine TMP resistant mutants or
strains filamenting in the presence of the drug. Among
these mutants were knock-outs of uvrA, a nuclease
component of the nucleotide excision repair, and of recJ,
a single strand DNA exonuclease. A loss of recJ function
was reported to alleviate the lethal effect of the thymine
starvation [37,39,41], which is believed to be the primary
bactericidal mechanism of TMP. Knock-outs of two of
the genes involved in deoxypyrimidine nucleotide sal-
vage pathway, deoC and deoA, were found to be among
resistant candidates, whereas a knock-out of the repres-
sor of the deoCABD operon, deoR,w a sf o u n dt ob e
more susceptible to TMP. deoC, deoA and deoR mutants
grew in LB without the drug as well as their isogenic
parental strain. Of note, the deoCABD operon was
down-regulated during LBTMP treatment and was
a m o n gt h et o pd o w n - r e g u l a t e dg e n es e t s / p a t h w a y si n
the condition. This enrichment of a single metabolic
pathway and its regulator in the TMP phenotypic screen
along with its transcriptional signature, and given the
central role of the pathway in the conversion of thymi-
dine and uridine nucleosides into nucleotides, led us to
investigate these genes in more detail.
Table 2 List of mutants yielding high biomass in
presence of TMP at sub-lethal concentrations in LB
medium
Resistant knock-out candidates
Gene Gene
ID
Description
moaE b0785 Molybdopterin (MPT) synthase, large subunit; chlorate
resistance; dimer of dimers with MoaD
ybhN b0788 Function unknown
yliE b0833 Function unknown
ymfQ b1153 Function unknown
yobG b1826 Function unknown
yecN b1869 Function unknown
crr b2417 Phosphocarrier protein for glucose of the PTS; Enzyme
IIA(Glc); formerly EIII(glc)
recJ b2892 Single-stranded DNA-specific exonuclease, 5’-3’
ygjT b3088 Function unknown; induced by alkali; putative
membrane transport or efflux protein
ygjU b3089 Na+/serine (threonine) symporter
nanA b3225 N-Acetylneuraminate lyase (aldolase)
yhiP b3496 Function unknown
uhpT b3666 Fosfomycin sensitivity; sugar P transport system;
transport protein for hexose P’s
yiiQ b3920 Function unknown
uvrA b4058 Excision nuclease subunit A; repair of UV damage to
DNA; LexA regulon; binds Zn(II)
fimE b4313 Site-specific recombinase for fimA promoter segment
inversion; bias for ON to OFF phase switching
deoC b4381 Deoxyribose-phosphate aldolase; deoxyriboaldolase;
binds selenium
deoA b4382 Thymidine phosphorylase
A total of 18 mutants, based on their relatively high biomass yield in presence
of TMP, were identified as sensitive candidates. Genes whose functions are
related to DNA maintenance and nucleotide salvage pathway are highlighted
in bold. Genes are sorted by their Gene IDs.
Table 3 List of mutants yielding low biomass in presence
of TMP at sub-lethal concentrations in LB medium
Sensitive knock-out candidates
Gene Gene
ID
Description
deoR b0840 Repressor for deo operon, nupG and tsx; binds
deoxyribose-5-phosphate inducer
flgH b1079 Flagellar synthesis, basal body L-ring protein
fliD b1924 Hook-associated protein 2, axial family; flagellar
regulon
fliI b1941 Cytoplasmic membrane ATPase involved in flagellar
assembly; involved in export of flagellar axial protein
subunits
fliN b1946 Flagellar switch protein
JW5799 -
mdoH b1049 Membrane glycosyltransferase
tdk b1238 Deoxythymidine kinase
ycbC b0920 Function unknown
yciM b1280 Function unknown
ydhA b1639 Function unknown
yfgE
(hda)
b2496 Required for regulatory inactivation of DnaA;
multicopy suppressor of dnaN(ts)
alaS b2697 Alanine–tRNA ligase
A total of 13 mutants, based on their relatively low yields, were identified as
sensitive candidates. Genes whose functions are related to DNA maintenance
and nucleotide salvage pathway are highlighted in bold. Genes are sorted by
their Gene IDs.
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bose-5-phosphate aldolase (Dra/DeoC), thymidine phos-
hphorylase (Tpp/DeoA), pentophoshomutase (DeoB)
and purine nucleotide phosphorylase (Pnp/DeoD). DeoA
catalyzes the reversible interconversion between thymine
and thymidine and between uracil and deoxyuridine.
The deoxyribose sugar donor is deoxyribose-1-phos-
phate, which is converted to deoxyribose-5-phosphate
(dR5P) by DeoB, and which is then degraded to glycoly-
tic intermediates by DeoC. The operon is under negative
control by DeoR. In the presence of metabolic inter-
mediate dR5P, the deo operon is derepressed, leading to
increased activity of the salvage pathway [42,43]. The
knock-out mutations in the deo genes were transferred
into MG1655 background by P1 transduction (Meth-
ods). First we examined if the growth phenotype of deo
mutants translated into viability phenotypes in LB med-
ium (Figure 4A). Viability of exponentially grown wild-
type E. coli MG1655 treated with TMP at 50 μg/ml
could be described by a typical by-phasic curve: a pro-
longed (120 min) lag followed by an exponential killing
phase, with 17% of initial colony forming units (CFU)
remaining after 3 hours of treatment. The cell mass (O.
D.) typically increased 2-4 fold due to cell filamentation
(Additional File 7). In comparison, MG1655 deoA
- cul-
ture retained 83% of the pre-treatment CFU’sa tt h e
same time, and a deoC
- culture grew more than 400% of
its original CFU’s indicating nearly complete masking of
the TMP effect. In contrast, a deoR knock-out sensitized
this strain to the drug, resulting in 97% killing after 3
hours. In a complex medium, bacteria can access
extracellular nucleotides and other precursors. It has
been shown that the effect of TMP depends on the pre-
sence of these precursors in the medium [44]. To check
for phenotypes of the deo mutants in a defined minimal
medium, we grew cells in M9 supplemented with glu-
cose at 0.4% and each of the folate dependent metabo-
lites methionine, glycine and adenosine at 50 μg/ml.
Upon treatment with TMP (50 μg/ml), the deo mutants
exhibited the phenotypes opposite to those observed in
LB, i.e. deoC
- and deoA
- mutants were much more sen-
sitive (6.3% and 3.1% surviving CFU, respectively) after 3
hours of treatment compared to wild-type (44%),
whereas deoR
- showed an intermediate phenotype with
18% survival (Figure 4B, Additional File 7). Addition of
thymine (thymidine for deoA
-) rescued these mutants
from TMP. In both conditions, loss of CFU’sw a s
accompanied by cell filamentation, indicating a block in
cell division (data not shown). In this assay, addition of
TMP appeared to have produced a phenocopy of inacti-
vation of thymidylate synthase, ThyA, which is required
for conversion of dUMP to dTMP, by starving it for the
essential methyl group donor, CH2-THF.
Thus the effect of the deo mutations on TMP activity
falls into two categories. One - affects thymidine and
thymidine/thymine scavenging from the reach medium.
In this category, deoC
- and deoA
- mutant cells were less
susceptible to the drug than the wild type under the
same treatment conditions by improving anabolism of
the nucleoside/nucleotide, and deoR
- made cells more
susceptible to TMP by de-repressing the thymi(di)ne
catabolism. Another - affects catabolism of dUTP/
A) deo mutants in LBTMP  B) deo mutants in M9TMPAdAA
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Figure 4 Viability phenotypes of deo
- and thyA
-deo
- mutants in LB and M9 media. A) Mutants in deoC (Δ), deoA (□) and deoR (○) and wild-
type E. coli MG1655 (◇) were treated with 50 μg/ml of TMP in LB medium. Viability was tracked by counting CFU’s (on LB plates after 16-hr
incubation at 37°C) in the cultures sampled at 1, 2 and 3 hours of the treatment. B) In minimal media with supplements M9TMPAdAA.
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Page 10 of 14dUMP/dU. In this category, both deoC
- and deoA
-
mutants were more susceptible to the drug action in the
minimal medium, where bacteria “relies” solely on de
novo pyrimidine synthesis. In more detail, the pheno-
types of the deo operon may be understood by examin-
ing the nucleotide salvage pathway (Figure 5). In the
presence of exogenous deoxyribose pyrimidines, the
pathway catabolizes the ribose sugars to form glyceral-
dehyde-3-phoshpate and acetaldehyde to be used in cen-
tral carbon metabolism. However, during thymine
starvation in thyA
- mutants and TMP treatment, the cell
salvages thymine, or thymidine, from the medium using
dR1P. In LBTMP condition, CH2-THF will eventually
deplete as cells run out of folate dependent metabolites,
causing dTMP (and hence dTTP) insufficiency. LB med-
ium contains thymidine (as ascertained by the sustained
growth of thyA
-deoA
- and thyA
- strains in the medium),
which is utilized. However, since thymidine is catabo-
lized to dR1P and its catabolic products, the equilibrium
of thymidine/thymine reversible conversion by thymi-
dine phosphorylase (DeoA) should be shifted toward
thymidine catabolism. Since thymidylate is catabolized,
cells eventually starve for dTTP and lose viability. The
deo operon is down-regulated in the LBTMP condition
as compared to before treatment, suggesting depletion
of dR5P caused by utilization of dR1P by thymine to
replenish thymidine for dTTP synthesis. In the absence
of functional deoA, cells are able to utilize all the thymi-
dine in the medium for dTTP synthesis, since it cannot
be catabolized to thymine. Furthermore, when deoC is
mutated, not only is thymidine not catabolized, the
accumulation of dR5P may also derepress deoA to allow
the scavenging of thymine from the medium. This
explains the refractory nature of the deoC and deoA
mutants to TMP in LB. It is likely that once thymidine
is exhausted from the medium, cells may continue on
their bactericidal trajectory provided they sustain contin-
ued growth in the presence of other folate dependent
metabolites, and provided TMP is effective in inhibiting
DHFR. However, when the operon is completely dere-
pressed due to the absence of deoR, the cells fail to
repress the catabolism of thymidine and they may run
out of thymidine quicker than wild-type strain in LB
explaining the sensitive phenotype.
In minimal medium supplemented with amino acids
and purine, cells cannot utilize exogenous thymine or
thymidine like in LB. dTTP depletion during thymine
starvation induces the ribonucleoside-diphosphate
reductases, which increases flux through the dTTP bio-
synthetic pathway and causes an accumulation of dCTP
and dUMP [45,46]. In M9TMPAdAA condition, we see
an up-regulation of the nrdAB, genes (log-ratio > 0.5)
responsible for the reduction of pyrimidine ribonucleo-
tides to dUTP, indicating that similar conditions may
exist during this treatment. The excess accumulated
dUTP can then get incorporated into DNA or can be
degraded to dUMP and further to deoxyuridine and
dR1P via the dUMP phosphatase YjjG [42,43,47]. During
thymine starvation, excess ribose sugar is secreted into
the medium, particularly in deoC
- mutants [48]. In a
deoA
- mutant, the cells lack the ability to degrade deox-
yuridine and this may lead to the increased accumula-
tion of dUMP and dUTP in the cells, possibly due to
the conversion of the accumulated deoxyuridine to
dUMP via thymidine kinase [49].
Similarly, in deoC
- mutant, dUMP cannot be catabo-
lized leading to dUTP accumulation. The slight differ-
ence in sensitivity in deoA and deoC to TMP (Figure
4B) could be attributed to the activity of uridine phos-
phorylase (Udp) which also degrades deoxyuridine at
much lower rate than DeoA [50]. Finally, the deoR
-
mutant should be similar to the wild-type since in the
wild-type, the deo operon is derepressed due to accumu-
lation of dR5P, and the loss of viability in deoR is similar
to that in the wild-type strain.
In the current study, we observed that the kinetics of
killing by TMP was similar to that by thymine starva-
tion: 1-2 hour lag is followed by a relatively rapid loss of
viability. Moreover, induction of the SOS response in
dUTP
dUMP
dTMP
dTDP
dTTP
Thd
Thy
dCyt
dUrd
dR1P
dR5P
G3P
acet.
Ura.
DeoR
1
2
3
4
5/6
2
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11
Figure 5 Schematics of a pyrimidine salvage pathway. Model of
deoxyribose nucleotide salvage pathway. Double dashed line
indicates block in a pathway due to gene deletion or in case of
pathway 9 (dUMP ® dTMP), block in pathway due to starvation of
cells for essential cofactor tetrahydrofolate (not shown) by TMP
treatment. Thymine and thymidine represent external metabolites
transported from the media. Genes associated with pathways: 1 -
cdd; 2 - deoA; 3 - deoB; 4 - deoC; 5 - tdk; 6 - yjjG; 7 - tdk; 8 - nudI/
dut; 9 - thyA; 10 - tmk; 11 - ndk. Abbreviations: dCyt: deoxycytidine;
dUrd.: deoxyuridine; Ura. - uracil; dR1P - deoxyribose-1-phosphate;
dR5P: deoxyribose-5-phosphate; G3P/acet.: glyceraldehyde-3-
phophate/acetaldehyde; Thd - thymidine (external); Thy - thymine
(external).
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indicating that DNA becomes damaged long before the
cells loose their ability to divide. The duration of the lag
stage can in principle be determined by two factors: 1-
the time it takes for dTTP to drop below a certain level
to cause replication fork arrest; 2 - the time it takes for
DNA damage to become irreversible. While the first fac-
tor can be postulated a priori; the second is derived from
the observation that the loss of RecA or RecBC function
shortens or eliminates the lag [41], suggesting that dou-
ble-strand break repair pathway has a capacity to reverse
some effects of the starvation. It is likely that the shorten-
ing of the lag in a deoR
- mutant in the rich medium was
due to faster depletion of the dTTP pool, and the pheno-
type of deoC
- and deoA
- mutants in the rich medium can
be viewed as an extension of the lag stage due to the pool
maintenance in the mutant cells effectively scavenging
thymi(di)ne. When both dTTP and dUTP pools become
fully exhausted, DNA damage becomes persistent and its
processing by some repair enzymes makes the damage
irreversible. Cells from this stage in the thymineless
death pathway cannot be recovered and that accounts for
a rapid decline in viability. In support of this view,
mutants that can’t process initial DNA damage, e.g., recF
-
, loose viability at a much-reduced rate following the lag
[39,41].
It appears that the primary factor in establishing the
rate of starvation-induced killing is a number of chro-
mosomal replication events in a bacterial population.
The higher the rate of initiation and the greater the
number of growing replication forks per chromosome,
the higher the probability of the irreversible chromoso-
mal collapse [40]. In principle, if the dTTP pool is effi-
ciently replenished with dUTP, that would prevent
replication fork arrest (at least in the current replication
cycle) and thus would reduce the probability of the sub-
sequent chromosomal collapse. Such replenishment
does not happen under conventional thymine starvation
in thyA auxotrophs because of the activity of dUTPase,
which efficiently hydrolyzes dUTP to dUMP and PPi
[51] and because of the yjjG-deo pathway, which catabo-
lizes excess dUMP and dU [42,43,47]. That is probably
why the thymineless death triggered by thymine starva-
tion in thymidylate auxotrophs is not affected by the
activity of uracil-N-glycosyase, the first enzyme in the
uracil base excision pathway [41,52]: although uracil
may be occasionally found in DNA from some mutant
TLD cells, its post-replicative excision would not matter
much since the chromosome would be already on its
way toward collapse from the fork arrest, i.e., for uracil
to be incorporated in a part of DNA, the replication
fork must traverse that part of DNA in the template,
incorporation of U signifies exhaustion of dTTP and
since dUTP are readily hydrolyzed, the fork that started
incorporating U’s is subject to an eminent arrest. As a
result, the kinetics of the viability loss would be deter-
mined by the frequency of fork arrests and not by the
frequency of other DNA lesions.
However, in the conditions that maybe prone to a
slower exhaustion of the dTTP pool, due to indirect or
limited inhibitory effect on the thymidylate synthase
and/or significant increase of dUTP over dTTP, incor-
poration of uracil may become a factor in determining
the outcome of dTTP starvation. For example, chromo-
somes that are fully replicated in the presence of suffi-
cient dUTP may eventually collapse as a result of uracil
excision repair, which could be initiated but not com-
pleted in the absence of dTTP or dUTP. That appears
to be the case in yeast treated with the antifolate inhibi-
tor aminopterin [53] and in animal cells treated with the
antifolate drug methotrexate [54]. We argue that at least
in deoC
- and deoA
- cultures treated with TMP, a frac-
tion of cells can complete the ongoing rounds of DNA
replication, using dUTP in combination with slowly
decaying dTTP supply, and these chromosomes would
collapse primarily because of uracil processing and not
because of replication fork arrest. Consistent with that is
the observation that the lag stage was not affected in the
deoC
- and deoA
- mutants; instead, the loss of viability
was relatively accelerated in these mutants - pointing at
an additional source(s) of irreversible DNA damage. It is
possible that TMP treatment of E. coli, independent of
the growth medium and similar to anti-folate treatments
in higher organisms, results in dUTP levels sufficient to
support DNA replication. Processing uracil out of such
DNA with UNG would be detrimental to the cells. This
assertion is supported in part by our observation that an
ung
- mutant yielded in our screen 3 times as much bio-
mass as an average strain (data not shown) and by
observations from a chemical genomics screen where
dut
- and ung
- mutants showed fitness defect, while dcd
-
showed fitness advantage in response to the TMP treat-
ment [55]. Thus, it is likely that depending on the
mechanism of thymine starvation (TMP versus direct
thymidylate deficiency) and despite apparent similarities
between them, different components of DNA metabo-
lism may contribute to the starvation outcomes.
Conclusion
Treatment of E. coli bacteria with the antibiotic Tri-
methoprim results in regulatory responses that can be
associated with the drug mechanism as well as treat-
ment conditions. Depending on the treatment condition,
the drug can have bacteriostatic or bactericidal effect.
The DNA damage response can be used to discriminate
between the bacterial killing, which is preceded by the
damage response, and the bacteriostasis, during which
t h ed a m a g er e s p o n s ed o e sn o td e v e l o p .T h ed r u g
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istic lag stage of the treatment. Mutations in the deoxyr-
ibose nucleotide salvage pathway can affect duration of
the lag as well as the rate of killing. The duration of the
lag is likely determined by the capacity of the cells to
buffer the effect of thymine starvation caused by the
drug, e.g., through dTTP pools. The rate of killing, how-
ever, is determined by the distribution of drug sensitiv-
ities across a bacterial population. The sensitivity of
individual cell in turn should be determined by its stage
in the replication and division cycles. We speculate that
Trimethoprim, by affecting replication and possibly divi-
sion cycles, makes uracil incorporation into DNA an
important source of the offending lesion in the drug-
induced thymine starvation.
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Additional file 1: Gene Sets. A list of gene sets used in the analysis and
individual genes that make up sets. The file contains two excel sheets:
“Gene Sets” enumerates all classified sets; “Gene Set membership”
classifies genes into sets: 1 - a member, 0 - not a member.
Additional file 2: Analysis code. R code used for the analysis of the
data and tools for retrieving individual gene set scores and generating
plots.
Additional file 3: Coefficients of a set score linear model on
individual supplements. Set scores and set coefficients obtained from
the linear model employed to assess the effects of individual
supplements (as described in main text).
Additional file 4: Gene Sets associated with the lethality phenotype.
List of gene sets up-regulated in bacteriostatic or bactericidal conditions
along with their linear model coefficients.
Additional file 5: Plots of gene set scores associated with the
lethality phenotype. Boxplots identifying the set score differences
between static and cidal conditions.
Additional file 6: Comparison of non-parametric (AUC) and
parametric (linear model FDR) significant tests for sets. Scatter plot
of AUC scores and False Discovery Rates (FDR) from the linear model
indicating strong correlation between the two measures of association
between set scores and cell phenotype.
Additional file 7: O.D. values of deo mutants after TMP treatment in
M9 and LB media. A) LBTMP treatment. Increase in O.D. (600 nm) after
50 μg/ml TMP treatment of wild-type MG1655 strain (blue), deoA (red),
deoC (green) and deoR (purple) knock-out mutants in LB medium. TMP
was added to respective cultures grown from overnight inoculum to
mid-log phase in LB medium at O.D. 0.37-0.42 (Time 0 hr). B)
M9TMPAdAA treatment. Increase in O.D. (600 nm) after 25 μg/ml TMP
treatment of wild-type MG1655 strain (blue), deoA (red), deoC (green) and
deoR (purple) knock-out mutants in M9 medium. TMP was added to
respective cultures grown from overnight inoculum to mid-log phase in
M9 medium at O.D. 0.25-0.35 (Time 0 hr).
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